Cargando…
Balneotherapy for Fibromyalgia Syndrome: A Systematic Review and Meta-Analysis
(1) Background: The efficiency of balneotherapy (BT) for fibromyalgia syndrome (FMS) remains elusive. (2) Methods: Cochrane Library, EMBASE, MEDLINE, PubMed, Clinicaltrials.gov, and PsycINFO were searched from inception to 31 May 2020. Randomized controlled trials (RCTs) with at least one indicator...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038322/ https://www.ncbi.nlm.nih.gov/pubmed/33916744 http://dx.doi.org/10.3390/jcm10071493 |
_version_ | 1783677348446470144 |
---|---|
author | Cao, Chun-Feng Ma, Kun-Long Li, Qian-Lu Luan, Fu-Jun Wang, Qun-Bo Zhang, Ming-Hua Viswanath, Omar Myrcik, Dariusz Varrassi, Giustino Wang, Hai-Qiang |
author_facet | Cao, Chun-Feng Ma, Kun-Long Li, Qian-Lu Luan, Fu-Jun Wang, Qun-Bo Zhang, Ming-Hua Viswanath, Omar Myrcik, Dariusz Varrassi, Giustino Wang, Hai-Qiang |
author_sort | Cao, Chun-Feng |
collection | PubMed |
description | (1) Background: The efficiency of balneotherapy (BT) for fibromyalgia syndrome (FMS) remains elusive. (2) Methods: Cochrane Library, EMBASE, MEDLINE, PubMed, Clinicaltrials.gov, and PsycINFO were searched from inception to 31 May 2020. Randomized controlled trials (RCTs) with at least one indicator were included, i.e., pain, Fibromyalgia Impact Questionnaire (FIQ), Tender Points Count (TPC), and Beck’s Depression Index (BDI). The outcome was reported as a standardized mean difference (SMD), 95% confidence intervals (CIs), and I(2) for heterogeneity at three observational time points. GRADE was used to evaluate the strength of evidence. (3) Results: Amongst 884 citations, 11 RCTs were included (n = 672). Various BT regimens were reported (water types, duration, temperature, and ingredients). BT can benefit FMS with statistically significant improvement at different time points (pain of two weeks, three and six months: SMD = −0.92, −0.45, −0.70; 95% CI (−1.31 to −0.53, −0.73 to −0.16, −1.34 to −0.05); I(2) = 54%, 51%, 87%; GRADE: very low, moderate, low; FIQ: SMD = −1.04, −0.64, −0.94; 95% CI (−1.51 to −0.57, −0.95 to −0.33, −1.55 to −0.34); I(2) = 76%, 62%, 85%; GRADE: low, low, very low; TPC at two weeks and three months: SMD = −0.94, −0.47; 95% CI (−1.69 to −0.18, −0.71 to −0.22); I(2) = 81%, 0; GRADE: very low, moderate; BDI at six months: SMD = −0.45; 95% CI (−0.73 to −0.17); I(2) = 0; GRADE: moderate). There was no statistically significant effect for the TPC and BDI at the remaining time points (TPC at six months: SMD = −0.89; 95% CI (−1.85 to 0.07); I(2) = 91%; GRADE: very low; BDI at two weeks and three months: SMD = −0.35, −0.23; 95% CI (−0.73 to 0.04, −0.64 to 0.17); I(2) = 24%, 60%; GRADE: moderate, low). (4) Conclusions: Very low to moderate evidence indicates that BT can benefit FMS in pain and quality-of-life improvement, whereas tenderness and depression improvement varies at time phases. Established BT regimens with a large sample size and longer observation are needed. |
format | Online Article Text |
id | pubmed-8038322 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-80383222021-04-12 Balneotherapy for Fibromyalgia Syndrome: A Systematic Review and Meta-Analysis Cao, Chun-Feng Ma, Kun-Long Li, Qian-Lu Luan, Fu-Jun Wang, Qun-Bo Zhang, Ming-Hua Viswanath, Omar Myrcik, Dariusz Varrassi, Giustino Wang, Hai-Qiang J Clin Med Review (1) Background: The efficiency of balneotherapy (BT) for fibromyalgia syndrome (FMS) remains elusive. (2) Methods: Cochrane Library, EMBASE, MEDLINE, PubMed, Clinicaltrials.gov, and PsycINFO were searched from inception to 31 May 2020. Randomized controlled trials (RCTs) with at least one indicator were included, i.e., pain, Fibromyalgia Impact Questionnaire (FIQ), Tender Points Count (TPC), and Beck’s Depression Index (BDI). The outcome was reported as a standardized mean difference (SMD), 95% confidence intervals (CIs), and I(2) for heterogeneity at three observational time points. GRADE was used to evaluate the strength of evidence. (3) Results: Amongst 884 citations, 11 RCTs were included (n = 672). Various BT regimens were reported (water types, duration, temperature, and ingredients). BT can benefit FMS with statistically significant improvement at different time points (pain of two weeks, three and six months: SMD = −0.92, −0.45, −0.70; 95% CI (−1.31 to −0.53, −0.73 to −0.16, −1.34 to −0.05); I(2) = 54%, 51%, 87%; GRADE: very low, moderate, low; FIQ: SMD = −1.04, −0.64, −0.94; 95% CI (−1.51 to −0.57, −0.95 to −0.33, −1.55 to −0.34); I(2) = 76%, 62%, 85%; GRADE: low, low, very low; TPC at two weeks and three months: SMD = −0.94, −0.47; 95% CI (−1.69 to −0.18, −0.71 to −0.22); I(2) = 81%, 0; GRADE: very low, moderate; BDI at six months: SMD = −0.45; 95% CI (−0.73 to −0.17); I(2) = 0; GRADE: moderate). There was no statistically significant effect for the TPC and BDI at the remaining time points (TPC at six months: SMD = −0.89; 95% CI (−1.85 to 0.07); I(2) = 91%; GRADE: very low; BDI at two weeks and three months: SMD = −0.35, −0.23; 95% CI (−0.73 to 0.04, −0.64 to 0.17); I(2) = 24%, 60%; GRADE: moderate, low). (4) Conclusions: Very low to moderate evidence indicates that BT can benefit FMS in pain and quality-of-life improvement, whereas tenderness and depression improvement varies at time phases. Established BT regimens with a large sample size and longer observation are needed. MDPI 2021-04-03 /pmc/articles/PMC8038322/ /pubmed/33916744 http://dx.doi.org/10.3390/jcm10071493 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Cao, Chun-Feng Ma, Kun-Long Li, Qian-Lu Luan, Fu-Jun Wang, Qun-Bo Zhang, Ming-Hua Viswanath, Omar Myrcik, Dariusz Varrassi, Giustino Wang, Hai-Qiang Balneotherapy for Fibromyalgia Syndrome: A Systematic Review and Meta-Analysis |
title | Balneotherapy for Fibromyalgia Syndrome: A Systematic Review and Meta-Analysis |
title_full | Balneotherapy for Fibromyalgia Syndrome: A Systematic Review and Meta-Analysis |
title_fullStr | Balneotherapy for Fibromyalgia Syndrome: A Systematic Review and Meta-Analysis |
title_full_unstemmed | Balneotherapy for Fibromyalgia Syndrome: A Systematic Review and Meta-Analysis |
title_short | Balneotherapy for Fibromyalgia Syndrome: A Systematic Review and Meta-Analysis |
title_sort | balneotherapy for fibromyalgia syndrome: a systematic review and meta-analysis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038322/ https://www.ncbi.nlm.nih.gov/pubmed/33916744 http://dx.doi.org/10.3390/jcm10071493 |
work_keys_str_mv | AT caochunfeng balneotherapyforfibromyalgiasyndromeasystematicreviewandmetaanalysis AT makunlong balneotherapyforfibromyalgiasyndromeasystematicreviewandmetaanalysis AT liqianlu balneotherapyforfibromyalgiasyndromeasystematicreviewandmetaanalysis AT luanfujun balneotherapyforfibromyalgiasyndromeasystematicreviewandmetaanalysis AT wangqunbo balneotherapyforfibromyalgiasyndromeasystematicreviewandmetaanalysis AT zhangminghua balneotherapyforfibromyalgiasyndromeasystematicreviewandmetaanalysis AT viswanathomar balneotherapyforfibromyalgiasyndromeasystematicreviewandmetaanalysis AT myrcikdariusz balneotherapyforfibromyalgiasyndromeasystematicreviewandmetaanalysis AT varrassigiustino balneotherapyforfibromyalgiasyndromeasystematicreviewandmetaanalysis AT wanghaiqiang balneotherapyforfibromyalgiasyndromeasystematicreviewandmetaanalysis |